Search by Drug Name or NDC
NDC 69536-0425-60 Bronkaid 25; 400 mg/1; mg/1 Details
Bronkaid 25; 400 mg/1; mg/1
Bronkaid is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Foundation Consumer Healthcare LLC. The primary component is EPHEDRINE SULFATE; GUAIFENESIN.
Product Information
| NDC | 69536-0425 |
|---|---|
| Product ID | 69536-425_4528a201-937a-4c81-be74-d8fc89733243 |
| Associated GPIs | 43996202050340 |
| GCN Sequence Number | 064952 |
| GCN Sequence Number Description | ephedrine sulfate/guaifenesin TABLET 25-400MG ORAL |
| HIC3 | A1D |
| HIC3 Description | GENERAL BRONCHODILATOR AGENTS |
| GCN | 18743 |
| HICL Sequence Number | 036181 |
| HICL Sequence Number Description | EPHEDRINE SULFATE/GUAIFENESIN |
| Brand/Generic | Brand |
| Proprietary Name | Bronkaid |
| Proprietary Name Suffix | Dual Action Formula |
| Non-Proprietary Name | EPHEDRINE SULFATE and GUAIFENESIN |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 25; 400 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | EPHEDRINE SULFATE; GUAIFENESIN |
| Labeler Name | Foundation Consumer Healthcare LLC |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2022-12-31 |
Package
NDC 69536-0425-60 (69536042560)
| NDC Package Code | 69536-425-60 |
|---|---|
| Billing NDC | 69536042560 |
| Package | 5 BLISTER PACK in 1 CARTON (69536-425-60) / 12 TABLET, COATED in 1 BLISTER PACK |
| Marketing Start Date | 2006-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |